Role of Bumetanide in Treatment of Autism

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Autism

In brief

Role of bumetanide in Autism

Key facts

Study ID

NCT04766177

Run by

Sherief Abd-Elsalam

People needed

80

Starts

2021-01-01

Expected to finish

2030-12-01

Last updated by the study team

2021-02-23

Who can join

Age: 3 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients with ASD diagnosed by CARS rating Scale⩾30.
• Age of patients range between (3-12) years.

You may not qualify if…

• Patients with ASD associated with neurological antecedents (including epilepsies and febrile seizures), hepatic, renal dysfunction or electrocardiogram abnormalities and syndromatic children(Rett).

Where it is running

• Sherief Abd-Elsalam — Tanta, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.